Skip to main content
Log in

Multiple Metachronous Malignancies, One Patient with Three Primary Malignancies

  • Case Report
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

Development of a primary cancer after treatment of the first with radiotherapy or chemotherapy is well documented, but it is common with hematological malignancies. Variety of reasons are suggested by various researchers, but a conclusive evidence is not yet available. Excepting a few correlations like the tamoxifen therapy and endometrial cancer, angiosarcoma of the breast following radiotherapy, occurrence of other metachronous malignancies seem to be dependent on genetic and environmental factors. A patient with three primary malignancies is presented here.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Reingold SR, Neugut AI, Meadows AT (2000) Second cancers; incidence, risk factors and management. In: Holland JF, Frei E, Pollock RE, Weichselbaum RR, Bast RC, Kufe DW (eds) Cancer Medicine, Hamilton, ON, Canada, pp 2399–2406

  2. Cybulski C, Gorski B, Huzarski T et al (2004) CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet 75:1131–1135

    Article  PubMed  CAS  Google Scholar 

  3. Sadetzki S, Calderon-Margalit R, Peretz C et al (2002) Second primary breast cancer and thyroid disorders. Cancers Causes and Controls 14:367–375

    Article  Google Scholar 

  4. Ronckers CM (2005) Thyroid cancer and multiple primary tumors in the SEER cancer registries. Int J Cancer 117:281–288

    Article  PubMed  CAS  Google Scholar 

  5. Rubino C, de Vathaire F, Dottorini ME et al (2003) Second primary malignancies in thyroid cancer patients. Br J Cancer 89:1638–1644

    Article  PubMed  CAS  Google Scholar 

  6. Verkooijen RBT, Smit JWA, Romijn JA et al (2006) The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer. Eur J Endocrinol 155(6):801–806

    Article  PubMed  CAS  Google Scholar 

  7. Agrawal S, Eng C (2006) Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer. Hum Mol Genet 15:777–787

    Article  PubMed  CAS  Google Scholar 

  8. Bergman I, Beelen M, Gallee M et al (2000) The comprehensive cancer centres’ ALERT group. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Lancet 356:881–887

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Devaji Rao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jayaraman, S., Balakrishnan, S. & Rao, D. Multiple Metachronous Malignancies, One Patient with Three Primary Malignancies. Indian J Surg 73, 377–379 (2011). https://doi.org/10.1007/s12262-011-0281-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-011-0281-y

Keywords

Navigation